What is the most common cause of renovascular hypertension?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Most Common Cause of Renovascular Hypertension

Atherosclerosis is the most common cause of renovascular hypertension, accounting for approximately 90% of all renovascular stenotic lesions. 1

Etiology of Renovascular Hypertension

  • Atherosclerotic disease (90% of cases) typically affects the aorto-ostial segment and proximal 1 cm of the main renal artery 1, 2
  • Fibromuscular dysplasia (FMD) is the second most common cause (10% of cases), typically affecting the middle and distal two-thirds of the renal artery 1, 2
  • Less common causes include:
    • Renal artery aneurysms 1, 2
    • Takayasu's arteritis 1
    • Atheroemboli and thromboemboli 1
    • Spontaneous renal artery dissection 1, 3
    • Arteriovenous malformations or fistulas 1, 3
    • Trauma (e.g., lithotripsy, direct injury, surgery) 1
    • Prior abdominal radiation therapy 1
    • Retroperitoneal fibrosis causing external compression 1

Demographic and Clinical Patterns

  • Atherosclerotic renovascular disease:

    • More common in older individuals 1, 4
    • Often associated with systemic atherosclerosis involving the aorta, coronary, cerebral, and peripheral arteries 1
    • Typically affects the origin and proximal portion of the renal arteries 1
  • Fibromuscular dysplasia:

    • Most commonly affects young to middle-aged women (25-50 years old) 1
    • Can occur in both genders at any age 1
    • Often involves both renal arteries 1
    • Has a characteristic angiographic "string of beads" appearance 1

Clinical Significance and Diagnosis

  • Renovascular hypertension accounts for 0.5-5% of all hypertension cases in the general population, but its prevalence increases to approximately 25% in elderly patients with end-stage renal disease 2
  • Screening tests for diagnosis include:
    • Duplex ultrasonography (recommended first-line screening test) 1, 2
    • Computed tomographic angiography (in individuals with normal renal function) 1
    • Magnetic resonance angiography 2

Management Considerations

  • Medical therapy is the preferred initial approach for renovascular hypertension 5
  • Revascularization should be considered when medical therapy is ineffective or causes severe impairment of renal function 6
  • Caution should be used with ACE inhibitors or ARBs in patients with bilateral renal artery stenosis due to risk of acute renal function deterioration 5
  • Angioplasty alone is the preferred treatment for fibromuscular dysplasia, while angioplasty with stenting is typically performed for atherosclerotic disease 5

Clinical Pitfalls

  • Atherosclerotic renal artery stenosis can develop in patients with a history of fibromuscular dysplasia as they age 7
  • Bilateral renal artery disease presents a diagnostic challenge as it is difficult to quantify the effect on blood pressure of one side versus the other 2
  • 10-20% of patients may develop an unacceptable rise in serum creatinine with ACE inhibitors or ARBs, particularly with volume depletion 5

Therefore, the answer to the question "What is the most common cause of renovascular hypertension?" is D. Renal artery atheroma.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Renovascular Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Renovascular hypertension - a primer for the radiologist.

Abdominal radiology (New York), 2024

Guideline

Initial Treatment Approach for Renovascular Hypertension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment options for renovascular hypertension.

Expert opinion on pharmacotherapy, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.